Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies - Takeaways - MDSpire

Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies

  • By

  • Xinyun Du

  • Hao Su

  • Yuexi Huang

  • Jiani Liu

  • Qiaoying Li

  • Xuping Yang

  • Xuemei Tao

  • Rong Li

  • April 13, 2026

  • 0 min

Share

  • 1

    Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and insulin resistance.

  • 2

    Gut dysbiosis and intestinal barrier dysfunction are implicated in the pathogenesis and progression of PCOS, affecting metabolic and reproductive functions.

  • 3

    Distinct gut microbial signatures in PCOS patients correlate with clinical features like hyperandrogenism and insulin resistance, indicating their potential role in disease severity.

  • 4

    Fecal microbiota transplantation studies suggest that gut microbiota may actively contribute to PCOS manifestations, highlighting its significance in disease mechanisms.

  • 5

    Microbiome-targeted interventions, including dietary changes and probiotics, offer promising new therapeutic avenues for managing PCOS and its associated complications.

Original Source(s)

Related Content